BUZZ-Verona hits record high after Merck's $10 billion acquisition

-1.98% Pre

Delist Pre

-0.62%

-0.24%

+0.23%

Merck & Co., Inc. MRK	98.27 98.27	-1.98% 0.00% Pre
Verona Pharma plc Sponsored ADR VRNA	106.91 106.91	Delist 0.00% Pre
Dow Jones Industrial Average DJI	48114.26	-0.62%
S&P 500 index SPX	6800.26	-0.24%
NASDAQ IXIC	23111.46	+0.23%

Updates

** U.S.-listed shares of lung therapy firm Verona Pharma VRNA.O I9SAy.F jump 20.7% to all-time high of $104.81

** Verona set of its best day in over 2 years, if gains hold

** Merck MRK.N will buy London-based Verona for about $10 billion

** Merck will pay $107 per American depository share for Verona

** Shares of Merck up 2.5% at $83.40

** The purchase price is a premium of about 23% to Verona ADS' last closing price

** The Financial Times first reported the deal on Wednesday

** Including session moves, Verona up 125.7%, Merck down 16.3% YTD

(Reporting by Christy Santhosh, Siddhi Mahatole and Kamal Choudhury)

((Christy.Santhosh@thomsonreuters.com))

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.